Wanjie Zhu

628 total citations · 1 hit paper
8 papers, 409 citations indexed

About

Wanjie Zhu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Wanjie Zhu has authored 8 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Cancer Research. Recurrent topics in Wanjie Zhu's work include RNA modifications and cancer (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer-related gene regulation (2 papers). Wanjie Zhu is often cited by papers focused on RNA modifications and cancer (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer-related gene regulation (2 papers). Wanjie Zhu collaborates with scholars based in China. Wanjie Zhu's co-authors include Sui Peng, Shuibin Lin, Zihao Dai, Hai‐Ning Liu, Junbin Liao, Baogang Peng, Shenghua Zhu, Shaoqiang Li, Lixia Xu and Lijian Liang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Wanjie Zhu

8 papers receiving 407 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression

2021 201 citations Zihao Dai, Hai‐Ning Liu et al. Molecular Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wanjie Zhu China	5	365	197	59	44	27	8	409
Guoquan Tao China	12	313 0.9×	239 1.2×	39 0.7×	38 0.9×	35 1.3×	22	423
Youchao Jia China	10	284 0.8×	189 1.0×	63 1.1×	23 0.5×	17 0.6×	16	356
Jingtao Tong China	7	242 0.7×	165 0.8×	60 1.0×	21 0.5×	13 0.5×	11	324
Junqi Luo China	8	255 0.7×	218 1.1×	45 0.8×	125 2.8×	18 0.7×	9	360
Juhong Wang China	12	419 1.1×	280 1.4×	83 1.4×	50 1.1×	26 1.0×	17	507
Zehai Huang China	8	199 0.5×	146 0.7×	37 0.6×	47 1.1×	39 1.4×	14	293
Jinye Xu China	9	232 0.6×	144 0.7×	61 1.0×	18 0.4×	21 0.8×	11	339
Youmao Tao China	11	259 0.7×	194 1.0×	63 1.1×	27 0.6×	12 0.4×	17	325
Weiwei Hong China	9	322 0.9×	358 1.8×	48 0.8×	81 1.8×	19 0.7×	17	470

Countries citing papers authored by Wanjie Zhu

Since Specialization

Citations

This map shows the geographic impact of Wanjie Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanjie Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanjie Zhu more than expected).

Fields of papers citing papers by Wanjie Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanjie Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanjie Zhu. The network helps show where Wanjie Zhu may publish in the future.

Co-authorship network of co-authors of Wanjie Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanjie Zhu. A scholar is included among the top collaborators of Wanjie Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanjie Zhu. Wanjie Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hu, Qiao, Wanjie Zhu, Jianjun Du, et al.. (2023). A GPX4-targeted photosensitizer to reverse hypoxia-induced inhibition of ferroptosis for non-small cell lung cancer therapy. Chemical Science. 14(34). 9095–9100. 24 indexed citations

2.

Dai, Zihao, Wanjie Zhu, Xinyue Zhang, et al.. (2023). METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Molecular Therapy. 31(11). 3225–3242. 30 indexed citations

3.

Hu, Qiao, Wanjie Zhu, Jianjun Du, et al.. (2022). A near-infrared GPX4 fluorescent probe for non-small cell lung cancer imaging. Chemical Communications. 59(3). 294–297. 15 indexed citations

4.

Chen, Zhihang, Wanjie Zhu, Shenghua Zhu, et al.. (2021). METTL1 promotes hepatocarcinogenesis via m⁷G tRNA modification‐dependent translation control. SHILAP Revista de lepidopterología. 11(12). e661–e661. 134 indexed citations

5.

Dai, Zihao, Hai‐Ning Liu, Junbin Liao, et al.. (2021). N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Molecular Cell. 81(16). 3339–3355.e8. 201 indexed citations breakdown →

6.

Ding, Rong, Yuan Gao, Peng Zhang, & Wanjie Zhu. (2020). Application of Sobolev-Volterra Projection and Finite Element Numerical Analysis of Integral Differential Equations in Modern Art Design. Dynamic Systems and Applications. 29(3). 1 indexed citations

7.

Zhu, Wanjie, Shuling Chen, & Huilin Jin. (2019). IDDF2019-ABS-0070 Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma. A128.1–A128. 1 indexed citations

8.

Chen, Zebin, Shuling Chen, Ruiming Liang, et al.. (2019). Can artificial intelligence support the clinical decision making for Barcelona clinic liver cancer stage 0/a hepatocellular carcinoma in China?. Journal of Clinical Oncology. 37(15_suppl). e15634–e15634. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact